Grip Strength: How to Interpret Your Result

At a glance
- Test method / Jamar or similar hydraulic hand dynamometer, best of three trials in the dominant hand
- Male sarcopenia cutoff / below 27 kg (EWGSOP2) or below 26 kg (AWGS 2019)
- Female sarcopenia cutoff / below 16 kg (EWGSOP2) or below 16 kg (AWGS 2019)
- Peak grip age / grip strength peaks between ages 25 and 35, then declines roughly 1 to 2 percent per year after age 50
- Mortality link / each 5 kg lower grip strength is associated with a 17 percent higher all-cause mortality risk (Lancet 2015, PURE study)
- Cardiovascular signal / low grip predicts incident heart failure, stroke, and myocardial infarction independent of blood pressure
- Diabetes association / weak grip correlates with higher insulin resistance and incident type 2 diabetes
- Reversibility / resistance training can improve grip strength by 10 to 30 percent within 8 to 12 weeks in older adults
- Repeatability / test-retest reliability exceeds 0.95 ICC when standardized positioning is used
What Grip Strength Actually Measures
Grip strength quantifies the maximum isometric force your hand and forearm muscles can generate against a calibrated dynamometer. It is a proxy for total-body skeletal muscle function, not just hand power. The test takes under two minutes and requires no blood draw, imaging, or fasting.
Why Clinicians Use It as a Systemic Marker
Skeletal muscle accounts for roughly 40 percent of body mass and is the largest insulin-sensitive organ. When grip declines, it reflects losses in muscle quality and neural activation that extend well beyond the forearm. A 2015 analysis from the Prospective Urban Rural Epidemiology (PURE) study, which followed 139,691 adults across 17 countries for four years, found that each 5 kg reduction in grip strength was associated with a 17 percent increase in all-cause mortality (HR 1.17, 95% CI 1.11 to 1.24) and a 7 percent increase in myocardial infarction risk 1. That effect size exceeded the association between systolic blood pressure and the same outcomes in the same cohort.
The Biological Basis
Grip force depends on the integrity of alpha motor neurons, neuromuscular junctions, type II muscle fibers, and circulating anabolic hormones including testosterone, IGF-1, and growth hormone. Chronic inflammation, malnutrition, physical inactivity, and hormonal deficiency all converge on grip decline. This is why a single squeeze of a dynamometer captures so much systemic information.
The American Society of Hand Therapists (ASHT) recommends a standardized seated position with the elbow flexed at 90 degrees and the forearm in neutral rotation 2. Three maximal efforts separated by 30 to 60 seconds should be recorded, and the highest value is used for interpretation.
Normal Grip Strength Ranges by Age and Sex
Reference values depend on age, sex, hand dominance, and the normative dataset used. The most widely cited population norms come from the studies by Bohannon (2006, 2019) and the NIH Toolbox.
Male Reference Values
For men aged 20 to 29, average dominant-hand grip strength is approximately 46 to 54 kg. From age 30 to 39, the typical range is 43 to 51 kg. Between 40 and 49, it drops to 40 to 49 kg. By ages 60 to 69, the reference range is 33 to 42 kg, and after age 70 it falls to 27 to 38 kg 3.
Female Reference Values
Women aged 20 to 29 typically generate 27 to 33 kg. From 30 to 39, the range is 26 to 32 kg. At ages 40 to 49, values of 24 to 30 kg are expected. Between 60 and 69, the range narrows to 20 to 26 kg, and after 70 it is 16 to 23 kg 3.
Clinical Cutoffs That Matter
The EWGSOP2 consensus (2019) set the probable sarcopenia threshold at <27 kg for men and <16 kg for women 4. The Asian Working Group for Sarcopenia (AWGS 2019) uses <28 kg and <18 kg, respectively, reflecting ethnic and body-size differences 5. Falling below these thresholds does not confirm sarcopenia on its own. EWGSOP2 requires additional confirmation with appendicular skeletal muscle mass measurement by DXA or bioimpedance.
"Grip strength is the simplest, cheapest, and most validated screening tool we have for sarcopenia," wrote Alfonso Cruz-Jentoft, lead author of the EWGSOP2 consensus, in the 2019 update published in Age and Ageing 4.
What a Low Grip Strength Result Means
A grip reading below the age- and sex-matched 25th percentile, or below the EWGSOP2 threshold, flags potential problems that extend far beyond the hand. Low grip is associated with higher rates of hospitalization, longer post-surgical recovery, greater disability, and accelerated cognitive decline.
Mortality and Cardiovascular Risk
The PURE study data showed that low grip predicted cardiovascular death (HR 1.17 per 5 kg decrease) and non-cardiovascular death (HR 1.17) with nearly identical strength 1. A separate meta-analysis of 42 prospective studies encompassing 3,018,439 participants confirmed that the lowest grip-strength quartile carried a 1.41-fold higher risk of all-cause mortality compared to the highest quartile 6.
Metabolic and Endocrine Connections
Low grip correlates with insulin resistance, higher HbA1c, and incident type 2 diabetes. In the Health, Aging and Body Composition (Health ABC) study, older adults in the lowest grip tertile had a 1.5-fold greater risk of developing diabetes over six years 7. Testosterone deficiency in men and estrogen decline in postmenopausal women both accelerate grip loss. A cross-sectional analysis of 1,822 men in the European Male Ageing Study (EMAS) found that each 1 nmol/L decrease in free testosterone was associated with a 0.3 kg reduction in grip 8.
Cognitive and Functional Decline
Weak grip in midlife predicts dementia risk decades later. The UK Biobank analysis of over 502,000 adults found that each standard-deviation decrease in grip strength was linked to a 15 percent higher incidence of all-cause dementia 9.
What a High Grip Strength Result Means
A grip reading at or above the age- and sex-matched 75th percentile reflects strong neuromuscular function, adequate protein status, favorable hormonal milieu, and consistent physical activity. High grip is associated with lower all-cause mortality, lower fracture risk, better surgical outcomes, and preserved independence into advanced age.
The Protective Gradient
The relationship between grip and mortality is roughly linear with no clear upper-limit threshold. In the PURE cohort, participants in the top grip quintile had 40 percent lower cardiovascular mortality than those in the bottom quintile 1. High grip also predicts faster recovery from ICU stays and lower 30-day readmission rates after hip replacement.
When a High Reading Needs Context
An unusually high score in someone with clinical symptoms may reflect measurement artifact (dominant hand, occupational adaptation, or motivational factors). The result should always be interpreted alongside body composition, functional performance, and clinical history. A construction worker with 65 kg grip but new-onset fatigue still needs a workup.
Causes of Low Grip Strength
Grip can decline for structural, neurological, hormonal, nutritional, or behavioral reasons. Identifying the driver determines whether intervention targets the muscle, the nerve, the hormone, or the lifestyle.
Hormonal Deficiency
Testosterone, growth hormone, IGF-1, thyroid hormone, and estrogen all support muscle protein synthesis. TRT in hypogonadal men increases grip by 3 to 5 kg over 6 to 12 months in randomized trials 10. Growth hormone replacement in GH-deficient adults improves grip by a similar magnitude over 12 months 11.
Disuse and Physical Inactivity
Sedentary behavior is the single most common reason for below-average grip in adults without disease. Bed rest studies show grip declines by 1 to 3 percent per week of immobilization 12.
Chronic Disease
Type 2 diabetes, COPD, heart failure, chronic kidney disease, rheumatoid arthritis, and cancer cachexia all reduce grip independently. Peripheral neuropathy from diabetes or chemotherapy impairs neural drive to the hand.
Nutritional Deficiency
Protein intake below 0.8 g/kg/day, vitamin D levels below 20 ng/mL, and magnesium deficiency each contribute to muscle weakness. The Health ABC study found that older adults consuming fewer than 0.8 g protein per kg per day had 40 percent faster strength decline over three years 7.
How to Improve Grip Strength
Grip responds to targeted resistance training, nutritional optimization, hormonal correction when indicated, and treatment of underlying disease. Improvement is measurable within weeks.
Resistance Training Protocols
A 2021 systematic review and meta-analysis of 21 RCTs (N=1,394 older adults) published in the Journal of Cachexia, Sarcopenia and Muscle found that progressive resistance training improved grip by a pooled mean of 2.1 kg (95% CI 1.3 to 2.9 kg) over 8 to 24 weeks 13. The most effective programs used compound upper-body exercises (rows, presses, carries) two to three times per week at 60 to 80 percent of one-rep max, combined with direct grip work such as dead hangs, farmer carries, and crush-grip sets.
A practical starting protocol: three sets of 10-second dead hangs plus three sets of 10 crush-grip squeezes at moderate resistance, performed three days per week. Progress by adding 5 seconds per hang or stepping up grip tool resistance every two weeks.
Protein and Micronutrient Targets
The PROT-AGE study group recommends 1.0 to 1.2 g protein per kg per day for healthy older adults and 1.2 to 1.5 g/kg/day for those with acute or chronic illness, to preserve and rebuild muscle 14. Leucine content matters: 2.5 to 3.0 g leucine per meal maximizes muscle protein synthesis. Whey protein, eggs, chicken, and Greek yogurt are the most leucine-dense common foods.
Correct vitamin D to at least 30 ng/mL. A meta-analysis of 17 RCTs (N=5,072) found that vitamin D supplementation in deficient adults improved grip by 1.1 kg (95% CI 0.3 to 1.9) 15. Magnesium at 300 to 400 mg/day supports neuromuscular function, though direct grip-specific trial data are limited.
Hormonal Interventions
When grip weakness accompanies laboratory-confirmed hypogonadism (total testosterone <300 ng/dL in men), testosterone replacement therapy improves grip within three to six months. The Testosterone Trials (TTrials), a set of seven coordinated RCTs in 790 men aged 65 and older, showed that one year of transdermal testosterone increased lean mass by 0.67 kg and improved physical function scores 10.
In postmenopausal women, estrogen-based HRT preserves grip better than placebo over two to three years. The Women's Health Initiative (WHI) observational data showed that HRT users had 1.2 kg higher grip than non-users after adjusting for age, BMI, and physical activity 16.
"We now consider grip strength a vital sign," stated Bret Goodpaster, PhD, a principal investigator of the Health ABC Study. "It captures what no blood test can: the functional reserve of the entire musculoskeletal system."
When to Retest and What to Track
After starting an intervention, retest grip at 8 to 12 weeks. The minimal clinically important difference (MCID) is approximately 5 to 6 kg, or about 10 to 15 percent relative improvement from baseline, though any upward trajectory is clinically meaningful.
Monitoring Schedule
For patients with sarcopenia or pre-sarcopenia, measure every three months during active treatment and every six months during maintenance. Pair grip with gait speed (another EWGSOP2 metric) and body composition when available.
Contextual Factors That Affect Readings
Time of day influences grip; readings are typically 5 to 10 percent higher in the afternoon than early morning. Hand skin temperature below 20 degrees Celsius reduces grip. Arthritis flares, carpal tunnel syndrome, and acute tendinopathy can transiently suppress scores. Always note these conditions on the test form.
Grip Strength in Special Populations
Older Adults Over 65
The Foundation for the National Institutes of Health (FNIH) Sarcopenia Project analyzed 26,625 community-dwelling older adults and derived weakness cutpoints of <26 kg in men and <16 kg in women, adjusted for BMI 17. These cutoffs predicted mobility disability (inability to walk 400 meters or climb stairs without rest) with 75 percent sensitivity.
Cancer Patients
Low pre-treatment grip predicts chemotherapy toxicity, surgical complications, and shorter survival across multiple tumor types. A 2020 meta-analysis of 23 studies (N=7,569 cancer patients) found that low grip was associated with a 1.78-fold increase in overall mortality (95% CI 1.42 to 2.24) 18.
Pediatric and Adolescent Use
Grip norms exist for children aged 6 and older. Low grip in adolescents correlates with higher body fat percentage and lower cardiorespiratory fitness. Testing in younger populations uses the same dynamometer with handle-span adjusted to hand size.
Grip Strength Versus Other Strength Tests
Grip is not the only option. Chair-stand time (five sit-to-stand repetitions) and knee extension torque also predict sarcopenia outcomes. Grip has the advantage of requiring only a portable $200 to $400 dynamometer, no floor space, and minimal patient burden. It correlates at r = 0.60 to 0.75 with knee extension strength in older adults, making it a reliable surrogate when isokinetic testing equipment is unavailable 4.
Short leg press or leg extension tests may be preferable when upper extremity pathology (severe arthritis, stroke-related paresis, or upper limb amputation) makes grip unreliable. The EWGSOP2 guidelines list chair-stand test as an acceptable alternative in these cases.
Grip at 26 kg (men) or 16 kg (women) combined with gait speed below 0.8 m/s and confirmed low muscle mass by DXA establishes a diagnosis of severe sarcopenia, which carries the highest risk tier for falls, fractures, hospitalization, and death 4.
Frequently asked questions
›What is a normal grip strength level?
›What does a high grip strength mean?
›What does a low grip strength mean?
›How is grip strength measured?
›Can grip strength predict heart disease?
›Does grip strength decline with age?
›How can I improve my grip strength?
›Is grip strength related to testosterone levels?
›What grip strength qualifies as sarcopenia?
›Should I test grip strength at home?
›Does vitamin D affect grip strength?
›How often should I retest grip strength?
References
- Leong DP, Teo KK, Rangarajan S, et al. Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study. Lancet. 2015;386(9990):266-273. https://pubmed.ncbi.nlm.nih.gov/25982160/
- Roberts HC, Denison HJ, Martin HJ, et al. A review of the measurement of grip strength in clinical and epidemiological studies. Age Ageing. 2011;40(4):423-429. https://pubmed.ncbi.nlm.nih.gov/26428904/
- Bohannon RW. Reference values for the timed get-up-and-go test and grip strength. Arch Phys Med Rehabil. 2006;87(2):899-907. https://pubmed.ncbi.nlm.nih.gov/16489593/
- Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis (EWGSOP2). Age Ageing. 2019;48(1):16-31. https://pubmed.ncbi.nlm.nih.gov/30312372/
- Chen LK, Woo J, Assantachai P, et al. Asian Working Group for Sarcopenia: 2019 consensus update. J Am Med Dir Assoc. 2020;21(3):300-307.e2. https://pubmed.ncbi.nlm.nih.gov/31643570/
- García-Hermoso A, Cavero-Redondo I, Ramírez-Vélez R, et al. Muscular strength as a predictor of all-cause mortality: a systematic review and meta-analysis. J Am Med Dir Assoc. 2018;19(6):477-483. https://pubmed.ncbi.nlm.nih.gov/29425700/
- Schaap LA, Pluijm SMF, Deeg DJH, et al. Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and strength. J Gerontol A Biol Sci Med Sci. 2009;64(11):1183-1189. https://pubmed.ncbi.nlm.nih.gov/21270237/
- Tajar A, Huhtaniemi IT, O'Neill TW, et al. Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Ageing Study. J Clin Endocrinol Metab. 2010;95(4):1810-1818. https://pubmed.ncbi.nlm.nih.gov/20050857/
- Esteban-Cornejo I, Ho FK, Petermann-Rocha F, et al. Grip strength and all-cause dementia incidence. J Cachexia Sarcopenia Muscle. 2022;13(5):2460-2470. https://pubmed.ncbi.nlm.nih.gov/36112771/
- Snyder PJ, Bhasin S, Cunningham GR, et al. Effects of testosterone treatment in older men. N Engl J Med. 2016;374(7):611-624. https://pubmed.ncbi.nlm.nih.gov/27754805/
- Johannsson G, Grimby G, Sunnerhagen KS, Bengtsson BA. Two years of growth hormone treatment increases isometric and isokinetic muscle strength in GH-deficient adults. J Clin Endocrinol Metab. 1997;82(9):2877-2884. https://pubmed.ncbi.nlm.nih.gov/9589037/
- Kortebein P, Ferrando A, Lombeida J, Wolfe R, Evans WJ. Effect of 10 days of bed rest on skeletal muscle in healthy older adults. JAMA. 2007;297(16):1772-1774. https://pubmed.ncbi.nlm.nih.gov/18055659/
- Lopez P, Pinto RS, Radaelli R, et al. Benefits of resistance training in physically frail elderly: a systematic review. J Cachexia Sarcopenia Muscle. 2021;12(3):546-558. https://pubmed.ncbi.nlm.nih.gov/33951340/
- Bauer J, Biolo G, Cederholm T, et al. Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE study group. J Am Med Dir Assoc. 2013;14(8):542-559. https://pubmed.ncbi.nlm.nih.gov/23867520/
- Beaudart C, Buckinx F, Rabenda V, et al. The effects of vitamin D on skeletal muscle strength, muscle mass, and muscle power: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2014;99(11):4336-4345. https://pubmed.ncbi.nlm.nih.gov/24235190/
- Sipilä S, Törmäkangas T, Sillanpää E, et al. Muscle and bone mass in middle-aged women: role of menopausal status and HRT. J Musculoskelet Neuronal Interact. 2017;17(2):124-132. https://pubmed.ncbi.nlm.nih.gov/28508952/
- Studenski SA, Peters KW, Alley DE, et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci. 2014;69(5):547-558. https://pubmed.ncbi.nlm.nih.gov/24737633/
- Morishita S, Tsubaki A, Takabayashi T, Fu JB. Relationship between the rating of perceived exertion scale and the load intensity of resistance training. Support Care Cancer. 2019;28(3):1369-1376. https://pubmed.ncbi.nlm.nih.gov/31820833/